Investors / Atria Ventures
Atria Ventures
Venture capital
Atria Ventures is a venture firm that invests up to $3M at inception and seed stages. It partners with founders building at the edge of computation and biology in the life sciences.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechcomputational biologygenerative aihealthtechpharma
Your fit with Atria Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAtria Ventures lists 12 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Seed, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (86%) and AI & Machine Learning (14%). 100% of its companies are based in United States. It invests most often alongside 8VC, Andreessen Horowitz and Gaingels.
Counts come from funding rounds that name Atria Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Atria Ventures' whole history. Rounds on record name 2 companies; its own site lists 12. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 100% |
| Series A | 0% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 2 | 0 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 30th | 12 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 100th | 100% of entries at pre-seed or seed |
| Evidence | 73th | 8% of companies confirmed by a round |
| Sector focus | 94th | 86% in its largest sector |
| Reach | 19th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| 8VC | 2 |
| Andreessen Horowitz | 2 |
| Gaingels | 2 |
| General Catalyst | 2 |
| Mana Ventures | 2 |
| 137 Ventures | 1 |
| Abstract | 1 |
| Accel | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers12100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 86% | 15% |
| AI & Machine Learning | 14% | 18% |
Co-investor network
who it backs companies with, and who they back togetherCompare Atria Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Atria Ventures| Date | Company | Stage |
|---|---|---|
| 7 Oct 2025 | Round | |
| 17 Sept 2025 | Seed |
Round details for Atria Ventures
Amounts, full round histories and every co-investor in Atria Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
12 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Abridge develops and provides generative AI for clinical conversations and documentation in healthcare. | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| Axiom Bio predicts and understands drug toxicity using experimental data and agentic intelligence to help scientists develop safer medicines. | Healthcare & Biotech | Portfolio page | ||
| Evolv develops and sells biomimetic products, including GLP-1 and GHK-Cu, for weight and hair growth | Healthcare & Biotech | Portfolio page | ||
| The company provides an AI platform for creating regulatory submissions. | Healthcare & BiotechAI & Machine Learning | Oct 2025Round | Page + round | |
| HairDAO is an open-source R&D network where patients and researchers collaborate to develop revolutionary new treatments for hair loss. | Healthcare & Biotech | Portfolio page | ||
| HoX provides integrated environments for frontier science | Healthcare & Biotech | Portfolio page | ||
| Lighten delivers complete clinical intelligence from EHR data | Healthcare & Biotech | Portfolio page | ||
| Orchestra Bio provides an intelligent management platform for biotech and pharma teams to advance their drug development programs. | Healthcare & Biotech | Portfolio page | ||
| Sleuth provides biopharma intelligence and strategic insights to biopharma teams | Healthcare & Biotech | Portfolio page | ||
| Specie Bio provides access to biospecimens and datasets through an AI-driven exchange platform | Healthcare & Biotech | Portfolio page | ||
| The company provides an AI platform for clinical trial patient recruitment | Healthcare & Biotech | Sept 2025Seed | Funding round | |
| Forus automates the process from prescription to affordable access for patients | Healthcare & Biotech | Portfolio page |
About this data
site last read 10 Nov 2026- Site
- atria.vc
- Last read
- 10 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 17 Sept 2025
- Companies checked
- 12
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Atria Ventures' profile as data
Pull Atria Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/atria.vc
# also
GET /v1/firms/atria.vc/portfolio
GET /v1/firms/atria.vc/coinvestors
GET /v1/firms/atria.vc/news